Aberrant promoter CpG island methylation of the hDAB2IP gene in colorectal cancer

Ji Wook Moon, Jung Ok Lee, Soo Kyung Lee, Ji Hae Kim, Ga Young You, Jin Kim, Hyeon Soo Kim, Sun-Hwa Park

Research output: Contribution to journalArticle

Abstract

Human DAB2IP (hDAB2IP), a novel GTPase-activating protein modulating Ras-mediated signaling, is a candidate tumor suppressor gene. However, promoter methylation of hDAB2IP in colorectal cancer (CRC) is poorly understood. To ascertain the mechanism of gene promoter hypermethylation in CRC cells, we investigated the promoter methylation status of hDAB2IP genes in four CRC cell lines using a methylation specific polymerase chain reaction (MS-PCR). The frequency of DNA methylation was detected in three of the four CRC cell lines. The hDAB2IP gene expression was examined and determined using a reverse transcription-PCR (RT-PCR) and immunoblot analysis in CRC cell lines. Gene expression was silenced or down-regulated in SW-480 with methylated hDAB2IP, but could be restored by treatment with 5-aza-2?-deoxycytidine, a DNA methyl-transferase inhibitor. The frequency of DNA methylation was detected in 10 of 25 colon tumors (40%), compared with 0 of 25 (0%) corresponding adjacent normal colon tissues (pB0.005). These results suggest that hDAB2IP methylation is frequently present in colon cancer, and gene silencing may play an important role in colorectal carcinogenesis.

Original languageEnglish
JournalEuropean journal of Clinical and Medical Oncology
Volume3
Issue number1
Publication statusPublished - 2011 May 23

Fingerprint

CpG Islands
Methylation
Colorectal Neoplasms
Genes
DNA Methylation
Cell Line
Colon
ras GTPase-Activating Proteins
Gene Expression
Polymerase Chain Reaction
Deoxycytidine
Neoplasm Genes
Gene Silencing
Transferases
Tumor Suppressor Genes
Colonic Neoplasms
Reverse Transcription
Carcinogenesis
DNA
Neoplasms

Keywords

  • Colon cancer
  • Hypermethylation
  • Methylation-specific polymerase chain reaction
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Oncology

Cite this

Aberrant promoter CpG island methylation of the hDAB2IP gene in colorectal cancer. / Moon, Ji Wook; Lee, Jung Ok; Lee, Soo Kyung; Kim, Ji Hae; You, Ga Young; Kim, Jin; Kim, Hyeon Soo; Park, Sun-Hwa.

In: European journal of Clinical and Medical Oncology, Vol. 3, No. 1, 23.05.2011.

Research output: Contribution to journalArticle

@article{a971a85985a647e9afd6c1459e2c0bef,
title = "Aberrant promoter CpG island methylation of the hDAB2IP gene in colorectal cancer",
abstract = "Human DAB2IP (hDAB2IP), a novel GTPase-activating protein modulating Ras-mediated signaling, is a candidate tumor suppressor gene. However, promoter methylation of hDAB2IP in colorectal cancer (CRC) is poorly understood. To ascertain the mechanism of gene promoter hypermethylation in CRC cells, we investigated the promoter methylation status of hDAB2IP genes in four CRC cell lines using a methylation specific polymerase chain reaction (MS-PCR). The frequency of DNA methylation was detected in three of the four CRC cell lines. The hDAB2IP gene expression was examined and determined using a reverse transcription-PCR (RT-PCR) and immunoblot analysis in CRC cell lines. Gene expression was silenced or down-regulated in SW-480 with methylated hDAB2IP, but could be restored by treatment with 5-aza-2?-deoxycytidine, a DNA methyl-transferase inhibitor. The frequency of DNA methylation was detected in 10 of 25 colon tumors (40{\%}), compared with 0 of 25 (0{\%}) corresponding adjacent normal colon tissues (pB0.005). These results suggest that hDAB2IP methylation is frequently present in colon cancer, and gene silencing may play an important role in colorectal carcinogenesis.",
keywords = "Colon cancer, Hypermethylation, Methylation-specific polymerase chain reaction, Tumor suppressor gene",
author = "Moon, {Ji Wook} and Lee, {Jung Ok} and Lee, {Soo Kyung} and Kim, {Ji Hae} and You, {Ga Young} and Jin Kim and Kim, {Hyeon Soo} and Sun-Hwa Park",
year = "2011",
month = "5",
day = "23",
language = "English",
volume = "3",
journal = "European journal of Clinical and Medical Oncology",
issn = "1759-8958",
publisher = "San Lucas Medical",
number = "1",

}

TY - JOUR

T1 - Aberrant promoter CpG island methylation of the hDAB2IP gene in colorectal cancer

AU - Moon, Ji Wook

AU - Lee, Jung Ok

AU - Lee, Soo Kyung

AU - Kim, Ji Hae

AU - You, Ga Young

AU - Kim, Jin

AU - Kim, Hyeon Soo

AU - Park, Sun-Hwa

PY - 2011/5/23

Y1 - 2011/5/23

N2 - Human DAB2IP (hDAB2IP), a novel GTPase-activating protein modulating Ras-mediated signaling, is a candidate tumor suppressor gene. However, promoter methylation of hDAB2IP in colorectal cancer (CRC) is poorly understood. To ascertain the mechanism of gene promoter hypermethylation in CRC cells, we investigated the promoter methylation status of hDAB2IP genes in four CRC cell lines using a methylation specific polymerase chain reaction (MS-PCR). The frequency of DNA methylation was detected in three of the four CRC cell lines. The hDAB2IP gene expression was examined and determined using a reverse transcription-PCR (RT-PCR) and immunoblot analysis in CRC cell lines. Gene expression was silenced or down-regulated in SW-480 with methylated hDAB2IP, but could be restored by treatment with 5-aza-2?-deoxycytidine, a DNA methyl-transferase inhibitor. The frequency of DNA methylation was detected in 10 of 25 colon tumors (40%), compared with 0 of 25 (0%) corresponding adjacent normal colon tissues (pB0.005). These results suggest that hDAB2IP methylation is frequently present in colon cancer, and gene silencing may play an important role in colorectal carcinogenesis.

AB - Human DAB2IP (hDAB2IP), a novel GTPase-activating protein modulating Ras-mediated signaling, is a candidate tumor suppressor gene. However, promoter methylation of hDAB2IP in colorectal cancer (CRC) is poorly understood. To ascertain the mechanism of gene promoter hypermethylation in CRC cells, we investigated the promoter methylation status of hDAB2IP genes in four CRC cell lines using a methylation specific polymerase chain reaction (MS-PCR). The frequency of DNA methylation was detected in three of the four CRC cell lines. The hDAB2IP gene expression was examined and determined using a reverse transcription-PCR (RT-PCR) and immunoblot analysis in CRC cell lines. Gene expression was silenced or down-regulated in SW-480 with methylated hDAB2IP, but could be restored by treatment with 5-aza-2?-deoxycytidine, a DNA methyl-transferase inhibitor. The frequency of DNA methylation was detected in 10 of 25 colon tumors (40%), compared with 0 of 25 (0%) corresponding adjacent normal colon tissues (pB0.005). These results suggest that hDAB2IP methylation is frequently present in colon cancer, and gene silencing may play an important role in colorectal carcinogenesis.

KW - Colon cancer

KW - Hypermethylation

KW - Methylation-specific polymerase chain reaction

KW - Tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=79956080261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956080261&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79956080261

VL - 3

JO - European journal of Clinical and Medical Oncology

JF - European journal of Clinical and Medical Oncology

SN - 1759-8958

IS - 1

ER -